Richard T Scott, M.D.,H.C.L.D.

Chief Executive Officer for IVIRMA Global

RMA New Jersey

Member of the Scientific Advisory Board
Richard T Scott, M.D.,H.C.L.D.

Biography

Richard T. Scott, Jr, MD, HCLD/ALD FACOG is the Chief Executive Officer for IVIRMA Global. Additionally, he is the Clinical Director, Andrology and Endocrinology Laboratory Director, and Embryology Director of RMANJ.

He is also the Embryology Laboratory Director for IVI Florida in Orlando. He is the Fellowship Director for the Jefferson- RMANJ fellowship director at Thomas Jefferson University and is the Director of the Division of Reproductive Endocrinology at Robert Wood Johnson Medical School of Rutgers University. He serves on the Board of Directors of IVIRMA Global, Equipo IVI, IVI America, RMANJ, RMA Philadelphia, IVIRMA Orlando, IVIRMA Saint Louis, and IVIRMA Northern California. He is also Chairman of the Board of Directors of a large not-for-profit specializing in embryo research – the Foundation for Embryonic Competence

Dr. Scott has served many roles in the American Society for Reproductive Medicine. He has also served on the national Board of Directors of Resolve and as Scientific Director as a member of the national Board of Directors for the American Fertility Association, both national patient advocacy groups helping infertile patients. Dr. Scott has served on the scientific advisory boards, including as Chairman, for several large pharmaceutical companies and biotechnology firms which do work in our field. Dr. Scott also organizes and chairs the largest review course in Reproductive Endocrinology – The Frontiers in Reproductive Medicine.

Dr. Scott is board certified in three specialties including Obstetrics and Gynecology, Reproductive Endocrinology, and as an Embryologist, Andrologist, and High Complexity Laboratory Director. He is also trained in Aerospace Medicine.

Dr. Scott serves as an Associate Editor of Fertility and Sterility and is an ad hoc reviewer for more than a dozen other journals. He has edited two textbooks. Dr. Scott has authored more than six hundred peer reviewed, invited contributions, chapters, and published abstracts. He has also been invited to speak more than five hundred times at international meetings, conferences, and grand rounds at major universities and teaching centers around the world on six continents. Dr. Scott’s research focuses on factors which influence the reproductive competence of individual embryos, oocytes, and spermatozoa, ovarian reserve, GnRH analogs, follicular stimulation, reproductive genetics, molecular genetics, and molecular biology. Dr. Scott has received more than forty seven awards for best research at major national and international meetings in embryology and Reproductive Endocrinology. He was named American College of Obstetrics and Gynecology Professor of the Year at age 32 in 1990.

Read more

Education and Training

BS Randolph Macon College (1979)
MD The University of Virginia (1983)
Residency Wilford Hall USAF Hospital (1987)
Fellowship The Jones Institute for Reproductive Medicine (1989)
Aerospace Medicine Brooks USAF Aerospace Medicine Center (1993)

Honors and recognition

The American Society for Reproductive Medicine Star Award 2017
ASRM Corporate Member Council In-training Award. The American Society for Reproductive Medicine Annual Meeting, Mentor, First Author Diego Marin 2017
SMRU Traveling Scholars Program Award The American Society for Reproductive Medicine Annual Meeting, Mentor, First Author Scott Morin, MD 2017</td
Excellence In-Training Award, Pacific Coast Reproductive Society Annual Meeting, Mentor, First Author, Rhea Chattopadhyay, MD 2017
SRBT Clinical Science Award, The American Society for Reproductive Medicine. Mentor, First Author Marie Werner, MD 2016
SRBT Basic Science Award, The American Society for Reproductive Medicine, First Author - Nathan Treff, PhD 2016
The American Society for Reproductive Medicine Star Award 2016
Scientific Program Prize Poster, The American Society for Reproductive Medicine, Annual Meeting, Mentor First Author Scott Morin, MD 2016
In-Training Award for Research, The American Society for Reproductive Medicine, Annual Meeting. Mentor Scott Morin, MD 2016
Mentor First Author, Caroline Juneau, MD Excellence In-Training Award Pacific Coast Reproductive Annual Meeting 2016
Awarded ASRM Corporate Member In-Training Travel Grant, Annual Meeting of the American Society for Reproductive Medicine 2015
Mentor First Author Marie Werner 2015
Prize Paper Award American Association of Bioanalysts Annual Meeting Mentor First Author Jason Franasiak, MD 2015
Fertility and Sterility Star Reviewer Award 2015
The American Society for Reproductive Medicine Star Award 2015
The American Society for Reproductive Medicine Star Award 2014
The American Society for Reproductive Medicine Star Award 2013
In-Training Award for Research, The American Society for Reproductive Medicine Annual Meeting, Mentor First Author Kathleen H. Hong, MD 2013
Third Prize Poster Award, The American Society for Reproductive Medicine Annual Meeting Mentor First Author Kathleen H. Hong, MD 2013
Third Place Paper Prize Award, The American College of Obstetricians Annual Clinical Meeting Mentor First Author Eric J. Forman, MD 2012
The American Society for Reproductive Medicine Star Award 2012
In-Training Award for Research, The American Society for Reproductive Medicine Annual Meeting. Mentor First Author, Eric Forman, MD 2012
The American Society for Reproductive Medicine Star Award 2011
Best Abstract, First Annual Research Day, Faculty Clinical Category Human Genetics Institute of New Jersey, Piscataway, NJ 2011
The American Society for Reproductive Medicine Star Award 2010
SART Prize Paper, The American Society for Reproductive Medicine Denver, CO. First Author - Nathan Treff, PhD 2010
General Program Prize Paper, The American Society for Reproductive Medicine, Denver, CO 2010
Best Oral Presentation - Research, Faculty Category, Atlantic Health 14th Annual Research Day, Morristown, NJ June 2010
SART Prize Paper, The American Society for Reproductive Medicine Atlanta, Georgia First Author Xin Tao 2009
General Program Prize Paper, The American Society for Reproductive Medicine, Washington D.C., First Author Nathan Treff, PhD 2007
Best Research Paper, AAB Annual Meeting and Educational Conference, Orlando Florida May 17-19 2007
Lifetime Achievement Award. American Infertility Association 2006
National Award for Patient Advocacy, RESOLVE 2004
Family Building Award, American Infertility Association 1999
Best fellow paper. The Armed Forces District Meeting of the American College of Obstetrics and Gynecology First Author - Gregory S. Neal, MD 1998
The American Society for Reproductive Medicine Star Award 1997
Selected as one of the “Best Doctors in the United States for 1997 Women” Good Housekeeping Magazine 1997
Best fellow paper. The Armed Forces District Meeting of the American College of Obstetrics and Gynecology, San Diego, California. First Author - Bradley T. Miller, M.D 1995
Chairman's Award - Best scientific paper at the Armed Forces District of the American College of Obstetrics and Gynecology, Seattle, Washington 1993
Best Resident Paper, The Armed Forces District Meeting of the American College of Obstetrics and Gynecology, Cincinnati, Ohio. First Author - Stanton A. Bailey, M.D 1991
Meeting of the American College of Obstetrics and Gynecology, Cincinnati, Ohio. 1991
Professor of the Year, Presented at the Armed Forces District 1991
Searle Award, Best Paper presented by a junior fellow at a district of the American College of Obstetrics and Gynecology. Annual Clinical Meeting of the American College of Obstetrics & Gynecology 1989
Best Poster, Annual Meeting of the American Fertility Society 1988
First Place Abstract, Resident Category, Armed Forces District Meeting of the American College of Obstetrics and Gynecology 1988
Chairman's Award, Armed Forces District Meeting of the American College of Obstetrics and Gynecology 1988
Best Paper by Physician in Training, International Fertility Society 1987

Publications


  • Laser acupuncture before and after embryo transfer improves In Vitro fertilization outcomes: A four- armed randomized controlled trial.
    Morin SJ, Fratterlli JL, Franasiak JM, Juneau CR, Scott RT.
    Medical Acupuncture, 29:56-64, 2017.

  • High relative deoxyribonucleic acid content of trophectoderm biopsy adversely affects pregnancy outcomes.
    Neal SA, Franasiak JM, Forman EJ, Werner MD, Tao X, Treff NR, Scott RT.
    Fertil Steril, 107: 731-736, 2017.

  • Enhanced Techniques to "Power" Embryonic Mitochondria Research.
    Scott RT.
    Fertil Steril, 107: 59-60, 2017.

  • Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.
    Saccone G, Schoen C, Franasiak JM, Scott RT, Berghella V.
    Fertil Steril, 107:430-438, 2017.

  • Expanded Carrier Screening in an Infertile Population: How Often is Clinical Decision Making Affected?
    Franasiak J, Olcha M, Bergh P, Hong K, Werner M, Forman E, Zimmerman R, Scott RT.
    Genet Med, 18:1097-1101, 2016.

  • A randomized and blinded comparison of qpcr and NGS based detection of aneuploidy in a cell line mixture model of blastocyst biopsy mosaicism.
    Goodrich D, Tao X, Bohrer C, Lonczak A, Xing T, Zimmerman R, Zhan Y, Scott RT, Treff NR.
    J Assist Reprod Genet, 33:1473-1480, 2016.

  • The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists.
    Sermon K, Capalbo A, Cohen J, Coonen E, De Rycke M, De Vos A, Delhanty J, Fiorentino F, Gleicher N, Griesinger G, Grifo J, Handyside A, Harper J, Kokkali G, Mastenbroek S, Meldrum D, Meseguer M, Montag M, Munné S, Rienzi L, Rubio C, Scott K, Scott RT, Simon C, Swain J, Treff N, Ubaldi F, Vassena R, Vermeesch JR, Verpoest W, Wells D, Geraedts
    J. Mol Hum Reprod, 22:845-57, 2016.

  • SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation carrier and normal blastocysts.
    Treff NR, Thompson K, Rafizadeh M, Chow M, Morrison L, Tao X, Garnsey H, Reda CV, Metzgar TL, Neal S, Jalas C, Scott RT, Forman EJ.
    J Assist Reprod Genet, 33:1115-9, 2016.

  • Why abandoning sustained implantation rate may be throwing the baby out with the bathwater.
    Forman EJ, Franasiak JM, Patounakis G, Scott RT.
    Hum Reprod, 31:1926-7, 2016.

  • The challenge of embryonic mosaicism in preimplantation genetic screening.
    Scott RT, Galliano D.
    Fertil Steril, 105:1150-2, 2016.

  • Embryonic aneuploidy does not differ among genetic ancestry according to continental origin as determined by ancestry informative markers.
    Franasiak J, Olcha M, Shastri S, Molinaro TA, Congdon H, Treff N, Scott RT.
    Hum Reprod, 31:2391-5, 2016.

  • Genotypically determined ancestry across an infertile population: ovarian reserve and response parameters are not influenced by continental origin.
    Olcha M, Franasiak JM, Shastri S, Molinaro TA, Congdon H, Treff NR, Scott RT.
    Fertil Steril, 106:475-80, 2016.

  • Free Vitamin D Does not vary through the Proliferative Phase of the Menstrual Cycle.
    Franasiak J, Wang X, Sun W, Molinaro T, Green K, Werner M, Juneau C, Morin S, Scott RT.
    Endocrine, 53:322-6, 2016.

  • CYP1A1 3801T>C Polymorphism is not Associated with Variations in Total Motile Sperm or Fertilization Rates with ICSI.
    Franasiak JM, Barnett R, Treff N, Scott RT.
    Fertil Steril, 106:481-6, 2016.

  • Local and systemic factors and implantation: what is the evidence??
    Fox C, Morin SJ, Jeong JW, Scott RT, Lessey BA.
    Fertil Steril, 105:873-84. 2016.

  • FMR1 gene CGG repeat variation within the normal range is not predictive of ovarian response in IVF cycles.
    Morin SJ, Tiegs AW, Franasiak JM, Juneau CR, Hong KH, Werner MD, Zhan Y, Landis J, Scott RT.
    Reprod Biomed Online, 32:496-502, 2016.

  • Both slowly developing embryos and a variable pace of luteal endometrial progression may conspire to prevent normal birth in spite of a capable embryo.
    Franasiak JM, Ruiz-Alonso M, Scott RT, Simón C.
    Fertil Steril, 105:861-6, 2016.

  • Genetic mutation that may contribute to failure of prolapse surgery in Caucasian women: A case-control study.
    St Louis S, Scott RT, Lewis C, Salamon C, Pagnillo J, Treff N, Taylor D, Culligan P.
    J Minim Invasive Gynecol, 23:726-30, 2016.

  • Next Generation Sequencing Based Comprehensive Chromosome Screening in Mouse Polar Bodies, Oocytes, and Embryos.
    Treff NR, Krisher RL, Tao X, Garnsey H, Bohrer C, Silva E, Landis J, Taylor D, Scott RT, Woodruff TK, Duncan FE.
    Biol Reprod, 94:76, 2016.

  • The challenge of embryonic mosaicism in preimplantation genetic screening.
    Scott RT, Galliano D.
    Fertil Steril, 105:1150-2, 2016.

  • Dehydroepiandrosterone (DHEA) supplementation results in supraphysiologic DHEA- S serum levels and progesterone assay interference that may impact clinical management in IVF.
    Franasiak JM, Thomas S, Ng S, Fano M, Ruiz A, Scott RT, Forman EJ.
    J Assist Reprod Genet, 33:387-91, 2016.

  • Sequential versus Monophasic Media Impact Trial (SuMMIT): a paired randomized controlled trial comparing a sequential media system to a monophasic medium.
    Werner MD, Hong KH, Franasiak JM, Forman EJ, Reda CV, Molinaro TA, Upham KM, Scott RT.
    Fertil Steril, 105:1215-21, 2016.

  • Multiple thrombophilic single nucleotide polymorphisms lack a significant effect on outcomes in fresh IVF cycles: an analysis of 1717 patients.
    Patounakis G, Bergh E, Forman EJ, Tao X, Lonczak A, Franasiak JM, Treff N, Scott RT.
    J Assist Reprod Genet, 33:67-73, 2016.

  • Endometrial microbiome at the time of embryo transfer: next generation sequencing of 16S ribosomal subunit.
    Franasiak JM, Werner MD, Juneau CR, Tao X, Landis J, Zhang Y, Treff NR, Scott RT.
    J Assist Reprod Genet, 33:129-36, 2016.

  • Reproductive tract microbiome in assisted reproductive technologies.
    Franasiak JM, Scott RT.
    Fertil Steril, 104:1364-71, 2015.

  • Introduction: Microbiome in human reproduction.
    Franasiak JM, Scott RT.
    Fertil Steril, 104:1341-3, 2015.

  • Development and validation of concurrent preimplantation genetic diagnosis for single gene disorders and comprehensive chromosomal aneuploidy screening without whole-genome amplification.
    Zimmerman RS, Jalas,C, Tao X, Fedick AM, Kim, J, Pepe RJ, Northrop LE., Scott RT, Treff NR.
    Fertil Steril, 105:286-94, 2016.

  • Investigating the optimal preconception TSH range for patients undergoing IVF when controlling for embryo quality.
    Green KA, Werner MD, Franasiak JM, Juneau CR, Hong KH, Scott RT.
    J Assist Reprod Genet, 32:1469-76, 2015.

  • Expression and characterization of three Aurora kinase C splice variants found in human oocytes.
    Fellmeth JE, Gordon D, Robins CE, Scott RT, Treff NR, Schindler K.
    Mol Hum Reprod, 21:633-44, 2015.

  • Elevated progesterone levels in women on DHEA supplementation likely represent assay interference.
    Forman EJ, Franasiak JM, Scott RT.
    J Assist Reprod Genet, 32:661, 2015.

  • 24-Chromosome PCR for aneuploidy screening.
    Werner MD, Scott RT, Treff NR.
    Curr Opin Obstet Gynecol, 27:201-5, 2015.

  • Endometrial disruption does not improve implantation in patients who have failed the transfer of euploid blastocysts.
    Werner MD, Forman EJ, Hong KH, Franasiak JM, Bergh PA, Scott RT.
    J Assist Reprod Genet, 32: 557-62, 2015.

  • Discordant Embryonic Aneuploidy Testing and Prenatal Ultrasonography Prompting Androgen Insensitivity Syndrome Diagnosis.
    Franasiak JM, Yao X, Ashkinadze E, Rosen T, Scott RT.
    Obstet Gynecol, 125: 383-6, 2015.

  • Vitamin D levels do not impact IVF outcomes following the transfer of a euploid blastocyst. Reply to Letter.
    Franasiak JM, Molinaro TA, Scott RT.
    Am J Obstet Gynecol, 212:413, 2015.

  • Vitamin D levels do not impact IVF outcomes following the transfer of a euploid blastocyst. Reply to Letter.
    Franasiak JM, Molinaro TA, Scott RT.
    Am J Obstet Gynecol, 212: 411-2, 2015.

  • Aneuploidy across individual chromosomes at the embryonic level in trophectoderm biopsies: changes with patient age and chromosome structure.
    Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, Scott RT.
    J Assist Reprod Genet, 31:1501-9, 2014.

  • Vitamin D levels do not affect IVF outcomes following the transfer of euploid blastocysts.
    Franasiak JM, Molinaro TA, Dubell EK, Scott KL, Ruiz AR, Forman EJ, Werner MD, Hong KH, Scott RT.
    Am J Obstet Gynecol, 212:315, 2015.

  • Clinically recognizable error rate after the transfer of comprehensive chromosomal screened euploid embryos is low.
    Werner MD, Leondires MP, Schoolcraft WB, Miller BT, Copperman AB, Robins ED, Arredondo F, Hickman TN, Gutmann J, Schillings WJ, Levy B, Taylor D, Treff NR, Scott RT.
    Fertil Steril, 102:1613-8, 2014.

  • Blastocyst transfer is not associated with increased rates of monozygotic twins when controlling for embryo cohort quality.
    Franasiak JM, Dondik Y, Molinaro TA, Hong KH, Forman EJ, Werner MD, Upham KM, Scott RT.
    Fertil Steril, 103:95- 100, 2015.

  • Defining the "sweet spot" for administered LH/FSH gonadotropin ratios during ovarian stimulation to protect against a clinically-significant late follicular rise in progesterone: An analysis of 10,280 first IVF cycles.
    Werner MD, Forman EJ, Hong KH , Franasiak JM, Molinaro TA, Scott RT.
    Fertil Steril, 102:1312-7, 2014.

  • Endometrial infusion of human chorionic gonadotropin at the time of blastocyst embryo transfer does not impact clinical outcomes: a randomized double-blind, placebo controlled trial.
    Hong KH, Werner MD, Upham KM, Kim TJ, Winslow A, EJ Forman, Scott RT.
    Fertil Steril, 102:1591-1595, 2014.
    Comparison of array comparative genomic hybridization and quantitative real-time PCR-based aneuploidy screening of blastocyst biopsies.
    Capalbo, A., Treff, N. R., Cimadomo, D., Tao, X., Upham, K., Ubaldi, F.M., Rienzi, L., Scott, RT.
    Eur J Hum Genet, 23:901-6, 2014.

  • Examining the temperature of embryo culture in IVF: a randomized controlled trial comparing traditional core temperature (37°C) to a more physiologic, cooler temperature (36°C).
    Hong KH, Lee H, Forman EJ, Upham KM, Scott RT.
    Fertil Steril, 102: 767-73, 2014.

  • Embryonic aneuploidy: overcoming molecular genetics challenges improves outcomes and changes practice patterns.
    Franasiak JM, Scott RT.
    Trends Mol Med, 20:499-508, 2014.

  • Reply to the Authors.
    Franasiak J, Forman E, Scott RT.
    Fertil Steril, 102:e4, 2014.

  • Polar body based aneuploidy screening is poorly predictive of embryo ploidy and reproductive potential.
    Salvaggio C, Forman EJ, Garnsey HM, Treff NR, Scott RT. Gueye l.
    J Assist Reprod Genet, 31:1221-6, 2014.

  • Improved sensitivity to detect recombination using qPCR for Dyskeratosis Congenita PGD.
    Gueye, N. A., Jalas, C., Tao, X., Taylor, D., Scott, RT, Treff, NR.
    JARG, 31:1227-30, 2014.

  • Comprehensive chromosome screening (CCS) with synchronous blastocyst transfer: Time for a paradigm shift.
    Scott RT, Franasiak JM, Forman EJ.
    Fertil Steril. 102:660-1, 2014.

  • Lack of association of KATNAL1 gene sequence variants and azoospermia in humans.
    Fedick AM, Eckert K, Thompson K, Forman EJ, Devkota B, Treff NR, Taylor D, Scott RT.
    J Assist Reprod Genet, 31:1065-71, 2014.

  • Embryology Training for Reproductive Endocrine Fellows in the Clinical Human Embryology Laboratory.
    Scott RT, Hong KH , Werner MD, Forman EJ, Upham KM, Ruiz A, Zhao T, Cheng M.
    J Assist Reprod Genet, 31(4):385-91, 2014.

  • The Nature of Aneuploidy with Increasing Age of the Female Partner: A Review of 15,169 Trophectoderm Biopsies Undergoing Comprehensive Chromosomal Screening.
    Franasiak J, Forman EJ, Hong KH, Werner M, Upham K, Treff NR, Scott RT.
    Fertil Steril, 101:656-663, 2014.

  • Obstetrical and neonatal outcomes from the BEST Trial: Single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery rates.
    Forman EJ, Hong KH, Franasiak JM, Scott RT.
    Am J Obstet Gynecol, 210:157, 2014.

  • The ethical implications of preimplantation genetic diagnosis.
    Gronowski AM, Scott RT, Caplan AL, Nelson LJ.
    Clin Chem, 60:25-8, 2014.

  • Could Safety Boards provide a valuable took to enhance the safety of reproductive medicine?
    Scott RT, DeZiegler N.
    Fertil Steril, 100: 1518-1523, 2013.

  • Uniparental disomy in the human blastocyst is exceedingly rare.
    Gueye NA, Devkota B., Taylor D., Pfundt R., Scott RT, Treff, N R.
    Fertil Steril, 101: 232 -236, 2014.

  • Reply of the authors.
    Meldrum DR, Scott RT, Schoolcraft WB.
    Fertil Steril, 100:e37-8, 2013.

  • Selecting the optimal time to perform biopsy for preimplantation genetics.
    Scott KL, Hong KH, Scott RT.
    Fertil Steril, 100: 608-614, 2013.

  • Reply of the authors.
    Scott RT, Forman EJ, Treff NR.
    Fertil Steril, 100:e7-8, 2013.

  • In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial.
    Forman EJ, Hong KH, Ferry KM, Tao X, Taylor D, Levy B, Treff NR, Scott RT.
    Fertil Steril, 100:100-107, 2013.

  • Extended culture and the risk of preterm delivery: Confounding by indication.
    Forman EJ, Werner MD, Scott RT.
    Hum Reprod, 28:2021, 2013.

  • The Paradigm of Clinical IVF is shifting: The Time to Incorporate Validated Technologies and an Enhanced Understanding of Physiology is now.
    Hong KH, Scott RT.
    J Clin Embryology, 16:104-106, 2013.

  • Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases IVF implantation and delivery rates: a randomized controlled trial.
    Scott RT, Ferry KM, Forman EJ, Hong KH, Scott KL, Taylor D, Tao X, Treff NR.
    Fertil Steril, 100:697-703, 2013.

  • Cleavage stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial.
    Scott RT, Ferry KM, Forman EJ, Zhao T, Treff NR.
    Fertil Steril, 100:624-30, 2013.

  • Comprehensive chromosome screening alters traditional morphology-based embryo selection: a prospective study of 100 consecutive cycles of planned fresh euploid blastocyst transfer.
    Forman EJ, Upham KM, Cheng MZ, Zhao T, Hong KH, Treff NR, Scott RT.
    Fertil Steril, 100:718-24, 2013.

  • Incidental identification of balanced translocation carrier patients through comprehensive chromosome screening of IVF-derived blastocysts.
    Treff NR, Forman EJ, Katz-Jaffe MG, Schoolcraft WB, Levy B, Scott RT.
    J Assist Reprod Genet, 30:787-91, 2013.

  • Next-generation sequencing for preimplantation genetic diagnosis. Letter to the Editor.
    Treff NR, Forman EJ, Scott RT.
    Fertil Steril, 99:e17-18, 2013.

  • Evaluation of targeted next-generation sequencing based preimplantation genetic diagnosis of monogenic disease.
    Treff NR, Fedick A. Tao X, Devkota B, Taylor D. Scott RT.
    Fertil Steril, 99:1377-1384, 2013.

  • Four-hour quantitative real-time polymerase chain reaction– based comprehensive chromosome screening and accumulating evidence of accuracy, safety predictive values and clinical efficacy.
    Treff NR, Scott RT.
    Fertil Steril, 99: 1049-1053, 2013.

  • Embryos whose polar bodies contain isolated reciprocal chromosome aneuploidy are almost always euploid.
    Forman EJ, Treff NR, Stevens JM, Garnsey HM, Katz-Jaffe MG, Scott RT, Schoolcraft WB.
    Hum Reprod, 28:502-8, 2013.

  • Comprehensive chromosome screening and embryo selection: moving toward single euploid blastocyst transfer.
    Forman EJ, Hong KH, Treff NR, Scott RT.
    Semin Reprod Med, 30:236-42, 2012.

  • Methods for comprehensive chromosome screening of oocytes and embryos: capabilities, limitations, and evidence of validity.Treff NR, Scott RT.
    J Assist Reprod Genet, 29:381-90, 2012.

  • Oocyte vitrification does not increase the risk of embryonic aneuploidy or diminish the implantation potential of blastocysts created after ICSI: a novel paired randomized controlled trial using DNA fingerprinting.
    Forman, EJ, Li X., Ferry KM, Scott KL, Treff NR. Scott RT.
    Fertil Steril, 98:644-9, 2012.

  • Delivery of a chromosomally normal child from an oocyte with reciprocal aneuploid polar bodies.
    Scott RT, Treff NR, Stevens J, Forman EJ, Hong KH, Katz-Jaffe MG, Schoolcraft WB.
    J Assist Reprod Genet, 29:533-7, 2012.

  • Blastocyst preimplantation genetic diagnosis of a mitochondrial DNA disorder.
    Treff, N.R. Tao, X., Campos, J., Su, J., Ferry, K.M., Levy, B., Scott, RT.
    Fertil Steril, 98:1236-1240, 2012.

  • Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study.
    Scott RT, Ferry KM, Su J, Tao X, Scott KL, Treff NR.
    Fertil Steril, 97:870-875, 2012.

  • Development and validation of an accurate quantitative real-time polymerase chain reaction – based assay for human blastocyst comprehensive chromosomal aneuploidy screening. Seminal Contribution.
    Treff NR, Tao X, Ferry KM, Su J., Taylor D, Scott RT.
    Fertil Steril, 97:819-824, 2012.

  • Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates.
    Forman EJ, Tao X, Ferry KM, Taylor D, Treff NR, Scott RT.
    Human Reproduction, 27:1217- 22, 2012.

  • Polar body morphology is not predictive of its cell division origin.
    Treff NR, Scott RT, Su J., Campos J., Stevens J., Schoolcraft W., Katz-Jaffe M.
    Journal of Assisted Reproduction and Genetics, 29:137-9, 2012.

  • Fertility after age 45: From natural conception to assisted reproductive technology and beyond.
    Forman EJ, Treff NR, Scott RT.
    Maturitas, 70:216-221, 2011.

  • Live birth outcome with trophectoderm biopsy, blastocyst vitrification and SNP microarray based comprehensive chromosome screening in infertile patients.
    Schoolcraft W, Treff NR, Stevens J., Ferry K, Katz-Jaffe M., Scott RT.
    Fertil Steril, 96:638-40,2011.

  • Telomere DNA deficiency is associated with development of human embryonic aneuploidy.
    Treff NR, Su J., Taylor D., Scott RT.
    PLoS Genetics, 7: e1002161, 2011.

  • Use of single nucleotide polymorphism microarrays to distinguish between balanced and normal chromosomes in embryos from a translocation carrier.
    Treff NR, Tao X, Schillings WJ, Bergh PA, Scott RT.
    Fertil Steril, 96: e58-e65, 2011.

  • Tracking embryo implantation using cell-free fetal DNA enriched from maternal circulation at 9 weeks gestation.
    Treff NR, Tao X, Su J, Lonzcak A., Northrop L., A. Ruiz, Scott RT.
    Mol. Hum. Reprod, 17:434-438, 2011.

  • SNP Microarray Based Concurrent Screening of 24 Chromosome Aneuploidy and Unbalanced Translocations in Preimplantation Human Embryos.
    Treff, N.R., Northrop, L.E., Kasabwala, K., Su, J., Levy, B., and Scott, RT.
    Fertil Steril, 95:1606-1612, 2011.

  • Single Cell Whole Genome Amplification Technique Impacts the Accuracy of SNP Microarray Based Genotyping and Copy Number Analyses.
    Treff NR, Su J, Tao X, Northrop L., Scott RT.
    Mol Hum Repro, 17: 335–343, 2010.

  • SNP microarray based 24 chromosome aneuploidy screening demonstrates that cleavage stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts.
    Northrop L., Treff NR, Levy B., Scott RT.
    Mol Hum Repro, 16:590-600, 2010.

  • SNP microarray based 24 chromosome aneuploidy screening is significantly more consistent than FISH.
    Treff NR, Levy B., Su J. ,Northrop L., Tao X, Scott RT.
    Mol Hum Repro, 16:583-9, 2010.

  • Assessing the reproductive competence of individual embryos: a proposal for the validation of new "-omics" technologies.
    Scott RT, Treff NR.
    Fertil Steril, 94:791-794, 2010.

  • A novel single-cell DNA fingerprinting method successfully distinguishes sibling human embryos.
    Treff NR, Su J, Tao X, Miller KA, Levy B, Scott RT.
    Fertil Steril, 94:477-484, 2010.

  • Accurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays.
    Treff NR, Su J, Tao X, Levy B, Scott RT.
    Fertil Steril, 94: 2017-2021, 2010.

  • Robust embryo identification using polar body single nucleotide polymorphism microarray based DNA fingerprinting.
    Treff NR, Su J, Kasabwala N, Tao X, Miller KA, Scott RT.
    Fertil Steril, 93: 2453-2455, 2010.

  • The p53 codon 72 single nucleotide polymorphism lacks a significant effect on implantation rate in fresh in vitro fertilization cycles: an analysis of 1,056 patients.
    Patounakis G, Treff N, Tao X, Lonczak A., Scott RT, Frattarelli J.
    Fertil Steril, 92:1290-6, 2009.

  • Adjuncts for ovarian stimulation: when do we adopt "orphan indications" for approved drugs?
    Meldrum DR, Chang RJ, de Ziegler D, Schoolcraft WB, Scott RT, Pellicer A.
    Fertil Steril, 92:13-8, 2009.

  • Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization: An analysis of 6021 pregnancies.
    Shamonki M., Frattarelli JL., Bergh PA, Scott RT.
    Fertil Steril, 91:1760-4, 2009.

  • Oral contraceptive pretreatment in women undergoing controlled ovarian stimulation in ganirelix acetate cycles may, for a subset of patients, be associated with low serum luteinizing hormone levels, reduced ovarian response to gonadotropins, and early pregnancy loss.
    Meldrum DR, Scott RT, Levy MJ, Alper MM, Noyes N.
    Fertil Steril, 91: 1963-1965, 2009.

  • A luteal estradiol for anticipated poor–responder patients may improve delivery rates.
    Hill MJ, McWilliams GD, Miller KA, Scott RT, Frattarelli JL.
    Fertil Steril, 91:739- 43, 2009.

  • Leukemia inhibitory factor induces cumulus expansion in immature human and mouse oocytes and improves mouse two-cell rate and delivery rates when it is present during mouse in vitro oocyte maturation.
    De Matos DG, Miller K, Scott RT, Tran CA, Kagan D, Nataraja SG, Clark A, Palmer S.
    Fertil Steril, 90:2367-2375, 2008.

  • Noninvasive metabolomic profiling of human embryo culture media using Raman spectroscopy predicts embryonic reproductive potential: a prospective blinded pilot study. Scott RT, Seli E, Miller K, Sakkas D, Scott K, Burns DH.
    Fertil Steril, 90: 77- 83, 2008.

  • A luteal estradiol protocol for poor-responders improves embryo number and quality.
    Frattarelli JL, Hill MJ, McWilliams GDE, Csokmay JM, Miller KA, Scott RT.
    Fertil Steril, 89:1118-1122, 2008.

  • The predictive value for IVF delivery rates is greatly impacted by the method used to select the threshold between normal and elevated basal FSH.
    Scott RT, Elkind-Hirsch KE, Styne-Gross A, Miller KA, Frattarelli JL.
    Fertil Steril, 89:868-78, 2008.

  • Male age negatively impacts embryo development and reproductive outcome in donor oocyte ART cycles. Scott RT, Elkind-Hirsch KE, Miller BT, Miller KA, Frattarelli JL.
    Fertil Steril, 90: 97- 103, 2008.

  • Low dose aspirin use does not improve in vitro fertilization outcomes in poor responders.
    Frattarelli JL, McWilliams GD, Hill MJ, Miller KA, Scott RT.
    Fertil Steril, 89: 1113- 1117, 2008.

  • Noninvasive metabolomic profiling of embryo culture media using Raman and near-infrared spectroscopy correlates with reproductive potential of embryos in women undergoing in vitro fertilization.
    Seli E, Sakkas D, Scott RT, Kwok SC, Rosendahl SM, Burns DH.
    Fertil Steril, 88:1350-7, 2007

  • Patient-friendly IVF: how should it be defined?
    Flisser E, Scott RT, Copperman AB.
    Fertil Steril, 88:547-9, 2007.

  • Adjuvant therapy enhances endometrial receptivity in patients undergoing assisted reproduction.
    Frattarelli JL, Miller BT, Scott RT.
    Reprod Biomed Online, 12:722-9, 2006.

  • Obesity does not impact implantation rates of pregnancy outcome in women attempting conception through oocyte donation.
    Styne-Gross A, Elkind-Hirsch KE, Scott, RT.
    Fertil Steril, 83:1629-34, 2005.

  • Assessment of Ovarian reserve. Is there still a role for ovarian biopsy? First do no harm!
    Sharra FL, Scott RT.
    Hum Reprod, 19:2426-, 2004.

  • Value of basal FSH: prognostic implications for pregnancy outcome.
    Styne-Gross A, Elkind-Hirsch KE, Scott RT.
    Human Reprod, 19:2426-7, 2004.

  • Diminished ovarian reserve and access to care.
    Scott RT.
    Fertil Steril, 81:1489-92;discussion 496-7, 2004.

  • Pregnancy after cryopreservation of donor oocytes and preimplantation genetic diagnosis of embryos in a patient with premature ovarian failure.
    Miller KA, Elkind-Hirsch K, Levy B, Grauber MD, Ross SJ, Scott RT.
    Fertil Steril, 82:211-4, 2004.

  • Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation.
    Pang S, Kaplan B, Karande V, Westphal LM, Scott RT, Givens C, Sacks P, Follistim Pen Trade Mark COH Study Group.
    Reprod Biomed Online, 7:319-26, 2003.

  • A new follicle aspiration set is equally effective and as well tolerated as the standard needle when used in a prospective randomized trial in a large in vitro fertilization program.
    Miller KA, Elkind-Hirsch K, Benson M, Bergh P, Drews M, Scott RT.
    Fertil Steril, 81:191-3, 2004.

  • An experimental bagatelle or a wrong mistake? Reply of the authors.
    Scott RT, Levi A.
    Fertil Steril, 78: 435-6, 2002.

  • Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation.
    Fluker M, Grifo J, Leader A, Levy M, Meldrum D, Muasher SJ, Rinehart J, Rosenwaks Z, Scott RT, Schoolcraft W, Shapiro DB.
    Fertil Steril, 75(1):38-45, 2001.

  • Reproductive outcome in patients with diminished ovarian reserve.
    Levi AJ, Raynault MF, Bergh PA, Drews MR, Miller BT, Scott RT.
    Fertil Steril, 76:666-9, 2001.

  • Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles.
    Levi AJ, Drews MR, Bergh PA, Miller BT, Scott RT.
    Fertil Steril, 76:670-4, 2001.

  • Evaluation of basal estradiol levels in assisted reproductive technology cycles.
    Frattarelli JL, Bergh PA, Drews MR, Sharara FI, Scott RT.
    Fertil Steril, 74:518-24, 2000.

  • Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles.
    Frattarelli JL, Lauria-Costab DF, Miller BT, Bergh PA, Scott RT.
    Fertil Steril, 74:512-7, 2000.
    Triplets: outcomes of expectant management versus multifetal reduction for 127 pregnancies.
    Leondires MP, Ernst SD, Miller BT, Scott RT.
    Am J Obstet Gynecol, 183:454-9, 2000.

  • Microdose follicular phase gonadotropin-releasing hormone agonist (GnRh-a) compared with luteal phase GnRh-a for ovarian stimulation at in vitro fertilization.
    Leondires MP, Escalpes M, Segars JH, Scott RT, Miller BT.
    Fertil Steril, 72:1018-23, 1999.

  • Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction.
    Kutteh WH, Schoolcraft WB, Scott RT.
    Hum Reprod, 14:2886-90, 1999.

  • Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone.
    Seifer DB, Scott RT, Bergh PA, Abrogast LK, Friedman CI, Mack CK, Danforth DR.
    Fertil Steril, 72:63-5, 1999.

  • Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction.
    Kutteh WH, Schoolcraft WB, Scott RT.
    Hum Reprod, 14:2886-90,1999.

  • Rapid visualization of metaphase chromosomes in single human blastomeres after fusion with in-vitro matured bovine eggs.
    Willadsen S, Levron J, Munne S, Shimmel T, Marquez C, Scott RT, Cohen J.
    Hum Reprod, 14:470-5, 1999.

  • Positive outcome after preimplantation diagnosis of aneuploidy in human embryos.
    Munne S, Magli C, Cohen J, Morton P, Sadowy S, Gianaroli L, Tucker M, Marquez C, Sable D, Ferraretti AP, Massey JB, Scott RT.
    Human Reprod, 14:2191-9, 1999.

  • Increased prevalence of antithyroid antibodies in women with recurrent pregnancy loss but not in women undergoing assisted reproduction.
    Kutteh WH, Yetman DL, Carr AC, Beck LA, Scott RT.
    Fertil Steril, 71:843-8,1999.

  • Human embryo fragmentation in vitro and its implications for pregnancy and implantation.
    Alikani M, Cohen H, Tomkin G, Garrisi GJ, Mack C, Scott RT.
    Fertil Steril, 71:836-42,1999.

  • Ooplasmic transfer in mature human oocytes.
    Cohen J, Scott RT, Alikani M, Schimmel T, Munne S, Levron J, Wu L, Brenner C, Warner C, Willadsen S.
    Mol Hum Reprod, 4:269-80, 1998.

  • First pregnancies after preconception diagnosis of translocations of maternal origin.
    Munne S, Scott RT, Sable D, Cohen J.
    Fertil Steril, 69:675-81, 1998.

  • Spontaneous abortions are reduced after preconception diagnosis or translocations.
    Munne S, Morrison L, Fung J, Marquez C, Weier U, Bahce M, Sable D, Grunfeld L, Schoolcraft B, Scott RT, Cohen J.
    J Assist Reprod Genet, 15:290-6, 1998.

  • The detection of diminished ovarian reserve in infertile women.
    Sharara FI, Scott RT, Seifer DB.
    Am J Obstet Gynecol, 179:804-12, 1998.

  • Response to Letters to the Editor. A negative study with power.
    Denis AL, Adler R, Scott RT.
    Fertil Steril, 69:166-8. 1998.

  • Use of anucleate donor oocyte cytoplasm in recipient eggs.
    Brenner C, Scott RT, Cohen J. Lancet, 350:961-3, 1997.

  • Birth of infant after transfer of anucleate donor oocyte cytoplasm into recipient eggs.
    Cohen J, Scott RT, Schimmel T, Levron J, Willadsen S.
    Lancet, 350:186-8, 1997.

  • Cryopreservation of single human spermatozoa.
    Cohen J, Garrisi GJ, Congedo-Ferrara TA, Kieck KA, Schimmel TW, Scott RT.
    Hum Reprod, 12:994-1001, 1997.

  • Antiphospholipid antibodies and pregnancy rates and outcome in IVF patients.
    Denis AL, Guido M, Adler RD, Bergh PA, Brenner C, Scott RT.
    Fertil Steril, 67:1084-90, 1997.

  • Reply to the letter to the editor. How much is left in the tank - can we tell?
    Hofmann GE, Scott RT.
    Fertil Steril, 66:1044, 1996.

  • Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact in pregnancy outcome.
    Hofmann GE, Khoury J, Johnson CA, Thie J, Scott RT.
    Fertil Steril, 66:980-6, 1996.

  • Characteristics of gonadotropin response, follicular development, and endometrial growth and maturation across consecutive cycles of clomiphene citrate treatment.
    Opsahl M, Fritz M, Scott RT.
    Fertil Steril, 66:533-7, 1996.

  • Endometrial thickness is predictive of histologic endometrial maturation in women undergoing hormone replacement for ovum donation.
    Hofmann GE, Thie J, Scott RT, Navot D.
    Fertil Steril, 66:380-4, 1996.

  • Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population.
    Hofmann GE, Sosnowski, Scott RT, Thie J.
    Fertil Steril, 66:49-53, 1996.

  • In vitro fertilization outcome in women with hydrosalpinx.
    Sharara FI, Scott RT, Marut EL, Queenan JT.
    Hum Reprod,11:526-30, 1996.

  • Intraobserver, interobserver variation of sperm critical morphology: comparison of examiner and computer-assisted analysis.
    Hofmann, GE, Santilli, BA, Kindig S, Scott RT, Johnson CA.
    Fertil Steril, 65:1021-5, 1996.

  • Not all assays are equal. Response to Letters-to-the-Editor.
    Scott RT, Hofmann GE.
    Fertil Steril, 65:892, 1996.

  • Differential down regulation of gonadotrope responsiveness following pulsatile GnRH-agonist administration in the presence and absence of long term GnRH-antagonist therapy.
    Illions EH, Scott RT, Carey KD, Navot D.
    Fertil Steril, 64:848-54, 1995.

  • Tru-Trax in vitro cervical mucus penetration test in predicting fertilization and pregnancy rates in in vitro fertilization.
    Sharara FI, Illions EH, Coddington CC, Scott RT.
    Human Reprod, 10:1481-5, 1995.

  • Life table analysis of cumulative pregnancy rates based on the results of ovarian reserve screening and patient age in a general infertility population.
    Scott RT, Opsahl MS, Leonardi MR, Neal GS, Illions EH, Navot D.
    Hum Reprod, 7:1706-10, 1995.

  • Response to the Letter to the Editor "Screening for Ovarian Reserve".
    Scott RT, Hofmann GE.
    Fertil Steril, 64:222-3, 1995.

  • Measures of Association - Smoking and Fecundity.
    Sharara FI, Scott RT.
    Fertil Steril, 63:1350-1, 1995.

  • Relationship between circulating hCG levels and premature luteinization in cycles of controlled ovarian hyperstimulation.
    Copperman AB, Horowitz GM, Kaplan P, Scott RT, Navot D, Hofmann GE.
    Fertil Steril, 63:1267-71, 1995.

  • Evaluation of the reproductive performance of women with elevated day 10 progesterone levels during ovarian reserve screening.
    Hofmann GE, Scott RT, Horowitz GM, Thie J, Navot D.
    Fertil Steril, 63:979-83, 1995.

  • In vivo effects of potent GnRH antagonist ORG 30850; Physiologic evidence that down-regulation of GnRH receptors does not occur.
    Gordon K, Scott RT, Williams RF, Danforth DR, Loozen HJJ, Kloosterboer HJ, Hodgen GD.
    J Soc Gynecol Invest, 1:290-6, 1994.

  • Use of the GnRH-agonist stimulation test in the diagnosis of ovarian remnant syndrome.
    Scott RT, Beatse SN, Illions EH, Snyder RR.
    J Reprod Med, 40:143-6, 1995.

  • Prognostic assessment of ovarian reserve.
    Scott RT, Hofmann GE.
    Fertil Steril, 63:1- 11, 1995.

  • Tru-trax in vitro cervical mucus penetration testing.
    Sharara FI, Beatse SN, Bailey SA, Neal GK, Coddington CC, Scott RT.
    Human Reprod, 9:2027-31, 1994.

  • Gonadotropin releasing hormone antagonist administration enhances gonadotrope responsiveness at doses inadequate to suppress circulating immunoassayable gonadotropin levels.
    Scott RT, Illions EH, Carey KD, Navot D.
    Fertil Steril, 62:1069-71, 1994.

  • Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test (CCCT).
    Sharara FI, Beatse SN, Leonardi MR, Navot D, Scott RT.
    Fertil Steril, 62:257-262, 1994.

  • Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate.**Archer DF, Pickar JH, Bottiglioni F, and the Menopause Study Group.
    Obstet Gynecol, 83:686-92, 1994.

  • Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone.
    **Woodruff JD, Pickar JH, and the Menopause Study Group.
    Am J Obstet Gynecol, 170:1213-23, 1994.

  • Comparison of leuprolide acetate and hCG for the induction of ovulation in clomiphene citrate stimulated cycles.
    Scott RT, Bailey SA, Kost ER, Neal GS, Illions EH.
    Fertil Steril, 61:872-9, 1994.

  • Enhancement of ovarian responsiveness with micro-doses of GnRH-agonist during ovulation induction for in vitro fertilization.
    Scott RT, Navot D.
    Fertil Steril, 61:880-5, 1994.

  • Immunohistochemical localization of transforming growth factor-$ in human implantation sites.
    Selick CE, Horowitz GM, Gratch M, Scott RT, Navot D, Hofmann GE.
    J Clin Endocrinol Metab, 78:592-6, 1994.

  • Penetration of human spermatozoa through the zona pellucida of non-viable human oocytes.
    Lanzendorf SE, Oehninger S, Scott RT, Whitelock SR, Hodgen GD.
    J Soc Gynecol Invest, 1:69-73, 1994.

  • Age related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation.
    Navot D, Drews MR, Bergh PA, Guzman I, Karstaedt A, Scott RT, Garrisi GJ, Hofmann GE.
    Fertil Steril, 61:97-101, 1994.

  • Evaluation of the impact of intra-observer variability on endometrial dating and the diagnosis of luteal phase defects.
    Scott RT, Snyder RR, Bagnall JW, Reed KD, Adair CF, Hensley SD.
    Fertil Steril, 60:652-7, 1993.

  • A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population.
    Scott RT, Leonardi MR, Hofmann GE, Illions EH, Neal GS, Navot D.
    Obstet Gynecol, 82:539-45, 1993.

  • The duration of leuprolide acetate administration prior to ovulation induction does not impact ovarian responsiveness to exogenous gonadotropins.
    Scott RT, Neal GS, Illions EH, Hayslip CA, Hofmann GE.
    Fertil Steril, 60:247-53, 1993.

  • Evaluation of the significance of a poor estradiol response during the clomiphene citrate challenge test.
    Scott RT, Dellinger CL, Leonardi MR, Illions EH, Hofmann GE, Navot D.
    Fertil Steril, 60:242-6, 1993.

  • Letter to the Editor regarding "Establishment of An Assisted Reproduction Program in the Armed Forces".
    Scott RT, Illions EH, Hayslip CA.
    Military Medicine, 158:A5, 1993.

  • Gonadotropin responsiveness to ultra low dose leuprolide acetate administration in baboons.
    Scott RT, Carey D, Leland M, Navot D.
    Fertil Steril, 59:1124-28, 1993.

  • Immunohistochemical localization of transforming growth factor- in human endometrium, decidua, and trophoblast.
    Horowitz GM, Scott RT, Drews MR, Navot D, Hofmann GE.
    J Clin Endocrinol Metab, 76:786-92, 1993.

  • Transforming growth factor-in human implantation trophoblast: Immunohistochemical evidence for autocrine/paracrine function.
    Hofmann GE, Horowitz GM, Scott RT, Navot D.
    J Clin Endocrinol Metab, 76:781-5, 1993.

  • Establishment of An Assisted Reproduction Program in the Armed Forces.
    Scott RT, Illions EH, Hayslip.
    Military Medicine, 158:92-6, 1993.

  • Creatine kinase as a marker for preterm labor.
    Satin AJ, Hankins GDV, Patterson WR, Scott RT.
    Am J Perinatology. 9:456-59, 1992.

  • Epidermal growth factor and its receptor in human implantation trophoblast: immunohistochemical evidence for autocrine/paracrine function.
    Hofmann GE, Drews MR, Scott RT, Navot D, Heller D, Delegdisch L.
    J Clin Endocrinol Metab, 74:981-8, 1992.

  • Results of a prenatal screening program for the human immunodeficiency virus in a cross-sectional population.
    Horowitz GM, Scott RT, Hankins GDV.
    J Reprod Med, 36:773-8, 1991.

  • Immunohistochemical localization of epidermal growth factor (EGF) in human endometrium, decidua and placenta.
    Hofmann GE, Scott RT, Bergh PA, Delegdisch L.
    J Clin Endocrinol Metab, 73:882-87, 1991.

  • Common errors in hysterosalpingography.
    Hofmann GE, Scott RT, Rosenwaks Z.
    Intl J of Fertility, 37:41-3, 1992.

  • A human in vivo model for the luteo-placental shift.
    Scott RT, Navot DM, Rosenwaks Z.
    Fertil Steril, 56:481, 1991.

  • Immunohistochemical localization of epidermal growth factor (EGF) in human endometrium, decidua and placenta.
    Hofmann GE, Scott RT, Bergh PA, Delegdisch L.
    J Clin Endocrinol Metab, 73:882-87, 1991.

  • The window of embryo transfer and the efficiency of human conception in vitro.
    Navot D, Scott RT, Droesch K, Veeck LL, Liu H-C, Rosenwaks Z.
    Fertil Steril, 55:114, 1991.

  • Embryo quality and pregnancy rates in patients attempting pregnancy through in vitro fertilization.
    Scott RT, Hofmann GE, Veeck LL, Jones HW, Muasher SJ.
    Fertil Steril, 55:426-28, 1991.

  • Pharmacokinetics of percutaneous estradiol: A crossover study using a gel and a transdermal system in comparison with oral micronized estradiol.
    Scott RT, Ross B, Anderson C, Archer DF.
    Obstet Gynecol, 77:758-64, 1991.

  • Acute Changes in serum estradiol concentrations do no elicit changes in serum osteocalcin concentrations.
    Scott RT, Karande VC, Archer DF.
    Ann NYAS, 592:472-3, 1990.

  • Pituitary luteinizing hormone (LH) secretion: Effect of different concentrations of serum 17ß-estradiol in postmenopausal women.
    Karande VC, Scott RT, Archer DF.
    Ann NYAS, 592:405-8, 1990.

  • Response to the editor.
    Scott RT.
    J In Vitro Fertil Embryo Transfer, 6:323, 1989.

  • Transplacental transfer of zidovudine (AZT) in the near term pregnant baboon.
    Hankins GDV, Lowery CL, Scott RT, Morrow WR, Carey KD, Leland MM, Colvin EV.
    Amer J Obstet Gynecol, 163:728-32, 1990.

  • Effects of leuprolide acetate on follicular fluid hormone composition at oocyte retrieval for in vitro fertilization.
    Brzyski RG, Hofmann GE, Scott RT, Jones HW.
    Fertil Steril, 54:842, 1990.

  • The relationship between serum estradiol-17ß concentrations and induced pituitary luteinizing hormone (LH) surges in post- menopausal women.
    Karande VC, Scott RT, Archer DF.
    Fertil Steril, 54:217, 1990.

  • Immunoreactive epidermal growth factor concentrations in follicular fluid obtained from in vitro fertilization.
    Hofmann GE, Scott RT, Brzyski RB, Jones HW, Jr.
    Fertil Steril, 54:303, 1990.

  • Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization.
    Scott RT, Hofmann GE, Oehninger SC, Muasher SJ, Rosenwaks Z.
    Fertil Steril, 54:297, 1990.
    Non-functional cysts do not affect ipsilateral or contralateral ovarian performance during in-vitro fertilization.
    Karande VC, Scott RT, Jones GS, Muasher SSJ.
    Human Reprod, 5:431, 1990.

  • The incidence of hyperprolactinemia in gonadotropin stimulated cycles for in vitro fertilization and its effect on cycle quality and pregnancy outcome.
    Hofmann GE, Denis AC, Scott RT, Muasher S.
    Fertil Steril, 52:622, 1989.

  • Effects of clomiphene citrate on episodic luteinizing hormone secretion throughout the menstrual cycle.
    Archer DF, Hofmann GE, Brzyski R, Ross B, Scott RT, Philput CB, Oehninger SC, Ware JC.
    Amer J Ob Gyn, 161:581, 1989.

  • Critical assessment of sperm morphology before and after double swim-up preparation for in vitro fertilization.
    Scott RT, Oehninger SC, Menkveld R, Veeck LL, Acosta AA.
    Arch Androl, 23:125, 1989.

  • Correlation of follicular diameter with oocyte recovery and maturity at the time of transvaginal aspiration.
    Scott RT, Hofmann GE, Muasher SJ, Acosta AA, Kreiner DK, Rosenwaks Z.
    J In Vitro Fertil Embryo Transfer, 6:73, 1989.

  • Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome.
    Scott RT, Toner JF, Muasher SJ, Oehninger SC, Robinson S, Rosenwaks Z.
    Fertil Steril, 51:651, 1989.

  • Hemizona assay (HZA): Assessment of sperm dysfunction and prediction of in vitro fertilization (IVF) outcome.
    Oehninger SC, Coddington CC, Scott RT, Franken D, Acosta AA, Hodgen GD.
    Fertil Steril, 51:665, 1989.

  • Validation of the hemizona assay (HZA) in a monkey model: Influence of oocyte maturational stages.
    Oehninger SC, Coddington CC, Scott RT, Franken D, Acosta AA, Hodgen GD.
    Fertil Steril, 51:881, 1989.

  • A prospective randomized comparison of single and double lumen needles for transvaginal follicular aspiration.
    Scott RT, Hofmann GE, Muasher SJ, Acosta AA, Kreiner DK, Rosenwaks Z.
    J In Vitro Fert Embryo Transfer, 6:98, 1989.

  • Maternal height and weight gain as risk factors for cesarean section.
    Scott RT, Strickland DM, Hankins GDV, Gilstrap LC.
    Military Medicine, 154:365, 1989.

  • Effects of the severity of tubo-ovarian disease and previous tubal surgery on the results of in vitro fertilization and embryo transfer.
    Oehninger SC, Scott RT, Muasher SJ, Acosta AA, Jones HW, Rosenwaks Z.
    Fertil Steril, 51:126, 1989.

  • Hormonal manipulation of endometrial manipulation.
    Navot DM, Anderson TL, Droesch KD, Scott RT, Kreiner DK, Rosenwaks Z.
    J Clin Endocr Metab, 68:801, 1989.

  • Ovulation induction for assisted reproduction.
    Scott RT, Rosenwaks Z.
    J Reprod Med, 34:42, 1989.

  • Assisted reproduction in the diagnosis and treatment of the male factor.
    Acosta AA, Oehninger SC, Morshedi M, Swanson RJ, Scott RT, Irianni F.
    Obstet Gynecol Surv, 44:1, 1989.

  • Transdermal estrogen replacement in ovarian failure for ovum donation.
    Droesch KW, Navot D, Scott RT, Kreiner DK, Liu HC, Rosenwaks Z.
    Fertil Steril, 50:931, 1988.

  • The effect of interobserver variation in dating endometrial histology in the diagnosis of luteal phase defects.
    Scott RT, Snyder RR, Strickland DM, Tyburski CC, Bagnall JA, Reed KR, Adair CA, Hensley SB.
    Fertil Steril, 50:888, 1988.

  • Spontaneous and pharmacologically induced remissions in patients with premature ovarian failure.
    Kreiner D, Droesch K, Navot D, Scott RT, Rosenwaks Z.
    Obstet Gynecol, 72:926, 1988.

  • Maternal arterial oxygen desaturation with treatment of uterine atony with 15-methyl prostaglandin F2 alpha.
    Hankins GDV, Berryman GR, Scott RT, Hood D.
    Obstet Gynecol. 72:367, 1988.
    Invited Articles and Contributions

  • Preimplantation Genetic Diagnosis and Screening.
    Franasiak J, Scott RT.
    Clinical Reproductive Medicine and Surgery, 3rd Edition. 2017.

  • Embryo and Endometrial Synchrony.
    Franasiak J, Scott RT.
    Recurrent Implantation Failure 2017

  • Microbiome and Implantation Failure.
    Franasiak J, Scott RT.
    Recurrent Implantation Failure 2017

  • Demographics of Cancer in the Reproductive Age Female.
    Franasiak J, Scott RT.
    Cancer and Infertility. 2016

  • Embryo Transfer and Post Transfer Care.
    Franasiak J, Scott RT.
    American Board Of Bioanalysts: Assisted Reproductive Technology. 2014 Revised 2016

  • Ovarian Stimulation.
    Franasiak J, Scott RT.
    American Board Of Bioanalysts: Assisted Reproductive Technology. Review Text 2014. Revised 2016

  • Preimplantation Genetic Diagnosis.
    Franasiak J, Scott RT.
    American Board Of Bioanalysts: Assisted Reproductive Technology. Review Text 2014 Revised 2016

  • A Brief History of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening.
    Franasiak JM, Scott RT.
    The Virtual Academy of Genetics, Controversies in Preconception, Preimplantation, and Prenatal Genetic Diagnosis, 2015.

  • “Mitochondrial DNA content as a viability score in human euploid embryos: less is better”.
    Journal Club Live Remote Online Discussion Panel Hosted by the REI Department at Washington University at St. Louis.
    Fertility and Sterility, 2015.

  • “Comparative Genomic Hybridization Microarray (aCGH) Analysis of DNA Isolated from the Blastocoel Fluid from 26 Blastocysts” and ‘‘Early Blastocysts’’: Worthy of a Biopsy in IVF Cycles with PGS?
    Journal Club Live Remote Online Discussion Panel.
    Fertility and Sterility, 2014.

  • Overview of PGD: Past, Present, & Future.
    Franasiak J, Scott RT.
    Prenatal Diagnosis.

  • Treatment of Low Responders. Textbook of Assisted Reproductive Techniques: Laboratory and Clinical Perspectives.
    Scott RT, Gardner DK, Weissman A, Howles C, Shoham Z.
    2nd edition. Taylor and Francis, 2004.

  • A New Highly Purified, Human-Derived FSH is Effective and Well Tolerated in Females Participating as Oocyte Donors for In Vitro Fertilization.
    Kaufmann RA, Gocial B, Crain JL, Webster BW, Scott RT, Miller PB, Elkind-Hirsch K, Scobey MJ. Bravelle.
    Today’s Therapeutic Trends, 21:1-14. 2003.

  • Oocyte Donation. Obstetrics and Gynecology
    Scott RT.
    ed JJ Sciarra, JB Lippincott Co, Philadelphia PA, 5:100. 2002.

  • Treatment of Low Responders. Textbook of Assisted Reproductive Techniques: Laboratory and Clinical Perspectives.
    Scott RT, Gardner DK, Weissman A, Howles C, Shoham Z,
    1st edition, Taylor and Francis, 2001.

  • Déjà vu all over again.
    Scott RT.
    Fertil Steril, 74:639-40. 2000.

  • Immunologic tests and IVF: “Please, enough already”.
    Hill JA, Scott RT.
    Fertil Steril, 74:439-42. 2000.

  • Pretreatment evaluation and screening for ART.
    Wolfe L, Miller B, Scott RT.
    ACOG Audio Updates, 1999

  • Genetic regulation of egg and embryo survival.
    Warner CM, Cao W, Exley GE, McElhinny AS, Alikani M, Cohen J, Scott RT, Brenner CA.
    Hum Reprod, 13 Suppl 3:179-90 discussion 191-6. 1998.

  • Ethics of guaranteeing patient outcomes: a complex issue whose time has not come.
    Scott RT, Silverberg K.
    Fertil Steril, 70:424-4. 1998.

  • Ovarian reserve screening.
    Sharara FI, Scott RT.
    Infert Reprod Med Clin NA, 8:501-522. 1997.

  • Clinical markers of gametogenic failure. Perimenopause
    Scott RT.
    Ed by Rogerio A. Lobo, Serono Symposia, 119-43. 1997.

  • Antiphospholipid antibodies and pregnancy rates and outcome in IVF patients.
    Scott RT, Denis AL, Guido M, Adler RD, Sable DB, Drews MR, Robins ED, Brenner C.
    In Vitro Fertilization and Assisted Reproduction, eds V Gomel and PCK Leung, Monteziore Editore, Bolgna, Italy, 855-60. 1997.

  • Evaluation of the prognostic significance of day 3 E2 levels in in vitro fertilization.
    Scott RT, Bergh PA, Sable DB, Drews MR, Robins ED, Sharara F, Cohen J.
    In Vitro Fertilization and Assisted Reproduction, eds V Gomel and PCK Leung, Monteziore Editore, Bolgna, Italy, 881-6. 1997.

  • Expression of bax mRNA associated with apoptosis in human oocytes and embryos.
    Brenner C, Exley G, Alikani M, Cohen J, Scott RT, Adler R, Warner C.
    In Vitro Fertilization and Assisted Reproduction, eds V Gomel and PCK Leung, Monteziore Editore, Bolgna, Italy, 627-32. 1997.

  • Evaluation of the prognostic significance of day 3 FSH:LH ratios in in vitro fertilization.
    Scott RT, Bergh PA, Sable DB, Robins, ED, Miller BT, and Cohen J.
    In Vitro Fertilization and Assisted Reproduction, eds V Gomel and PCK Leung, Monteziore Editore, Bolgna, Italy, 343-48. 1997.

  • Pregnancy after recovery of five testicular sperm cell cryopreserved under empty zona pellucida.
    Cohen J, Reing A, Garrisi GJ, Bar-Chama N, Scott RT.
    In Vitro Fertilization and Assisted Reproduction, eds V Gomel and PCK Leung, Monteziore Editore, Bolgna, Italy, 105-10. 1997.

  • Oocyte Donation.
    Scott RT.
    Obstetrics and Gynecology, ed JJ Sciarra, JB Lippincott Co, Philadelphia PA, 5:100. 1997

  • Evaluation and treatment of low responders.
    Scott RT.
    Semin in Reprod Endocrinol, 14:317-38. 1996.

  • Evaluation of the reproductive performance of women with elevated day 10 progesterone levels during ovarian reserve screening.
    Hofmann GE, Scott RT, Horowitz GM, Thie J, Navot D.
    Ob/Gyn Digest, Invited Abstract of Manuscript published in Fertility and Sterility, 27-29. 1995.

  • Epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), and their common (EGF) receptor. Potential relevance of this growth factor receptor system in normal human endometrium.
    Hofmann GE, Scott RT.
    Semin in Reprod Endocrin, 13:109-19. 1995.

  • Infertility after age 35: Diagnostic strategies.
    Seifer DB, Scott RT, Buyalos RP.
    Ob Gyn Management, 55-61. 1996.

  • The embryo, the endometrium and the patient. Perspectives on Assisted Reproduction.
    Navot D, Bergh PA, Hofmann GE, Drews M, Garrisi JG, Scott RT.; T Mori, T Tominaga, T. Aono, M. Hiroi.
    Ares-Serono Symposia Publications; Boston, MA, 347-52. 1994.

  • Prognostic assessment of ovarian reserve.
    Toner JA, Scott RT.
    Seminars in Reprod Endocrinol, 1-14. 1995.

  • Ultrasound monitoring of Controlled Ovarian Hyperstimulation.
    Scott RT.
    1994. (no journal)

  • Ultrasongoraphic evaluation of the endometrium during ovulation induction cycles.
    Scott RT.
    Imaging in Infertility and Reproductive Endocrinology, R Jaffe, R Pierson, and J Abramowicz eds. JB Lippincott, Philadelphia PA, 53-62. 1994.

  • The assisted reproductive technologies in the treatment of male factor infertility.
    Scott RT, Navot D.
    Management of Impotence and Infertility, edited by ED Whitehead and HM Nagler, Williams and Wilkins, Baltimore, MD, 321-38. 1994.

  • The use of oil overlay for in vitro fertilization and culture.
    Johnson CA, Hofmann GE, Scott RT.
    Assisted Reprod Rev, 4:198-201. 1994.

  • Evaluation of the significance of a poor estradiol response during the clomiphene citrate challenge test.
    Scott RT, Dellinger CL, Leonardi MR, Illions EH, Hofmann GE, Navot D.
    Fertility News, 3:19-21.1994.

  • Ultrasound monitoring. Ovarian Stimulation Monitoring: A roundtable review by L. Bonaventura.
    Scott RT.
    2nd in The Clinical Perspectives in Reproductive Endocrinology Series,1993.

  • Endometrial Ablation.
    Illions EH, Scott RT.
    San Antonio MD, 2:6-7. 1992. (no journal)

  • Primary amenorrhea.
    Drew MR, Scott RT, Hofmann GE.
    Adol Ped Gynecol, 4:119-28, 1990.

  • Hemizona assay: Assessment of human spermatozoa dysfunction and its correlation with in vitro fertilization results.
    Oehninger S, Scott RT, Muasher SJ, Coddington CC, Acosta AA, Hodgen GD.
    Advances in Assisted Reproductive Technologies, Edited by S Mashiach, Z Ben-Rafael, N Laufer and J Schenker. New York, Plenum Press, 515-24. 1990.

  • GnRH antagonists: New developments for indications in reproductive medicine.
    Hodgen GD, Kenigsberg D, Chillik C, Danforth Douglas, Leal J, Gordon, Scott RT, Williams R.
    Advances in Assisted Reproductive Technologies, Edited by S Mashiach, Z Ben-Rafael, N Laufer and J Schenker. New York, Plenum Press, 213-20. 1990.

  • Role of spermatozoa cryopreservation in assisted reproduction.
    Mahony MC, Morshedi M, Scott RT, De Villiers A, Erasmus E.
    Human Spermatozoa in Assisted Reproduction, eds Acosta AA, Swanson RJ, Ackerman SB, Kruger TF, van Zyl JA, Menkveld R. Williams & Wilkins, 310. 1990.

  • Spermatozoa motile fraction separation.
    Kruger TF, Menkveld R, Scott RT, Jeyendran RS, Zaneveld LJD, Windt ML.
    Human Spermatozoa in Assisted Reproduction, eds Acosta AA, Swanson RJ, Ackerman SB, Kruger TF, van Zyl JA, Menkveld R. Williams & Williams,181. 1990.

  • Oocyte Donation.
    Scott RT, Rosenwaks A.
    Obstetrics and Gynecology, ed JJ Sciarra, JB Lippincott Co, Philadelphia PA, 5:100. 1990.
    The ovarian follicle: Life cycle of a pelvic clock.
    Scott RT, Hodgen GD.
    Clin Obstet Gynecol, 33:551. 1990.

Read more

Videos

PGS and Mosaicism: what does the future hold?
Close Menu